Lv1
80 积分 2022-06-14 加入
Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system autoimmunity
18小时前
待确认
Statistical operating characteristics of current early phase dose finding designs with toxicity and efficacy in oncology
22天前
已完结
Anti-BCMA/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trial
2个月前
已完结
Anti-BCMA/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trial
2个月前
已完结
Clinical outcomes and microenvironment profiling in relapsed/refractory multiple myeloma patients with extramedullary disease receiving anti‐BCMA CAR T‐cell‐based therapy
2个月前
已完结
Genetic and epigenetic mechanisms of GPRC5D loss after anti-GPRC5D CAR T-cell therapy in multiple myeloma
2个月前
已完结
CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual targeting antibody overcome antigen heterogeneity in AML
2个月前
已完结
From TCR fundamental research to innovative chimeric antigen receptor design
2个月前
已完结
Next-Generation Chimeric Antigen Receptor T-Cell Therapy: Going off the Shelf
2个月前
已完结
Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell
2个月前
已完结
皖公网安备34019202002308
